Discharging a Patient with Upper GI Pain and Negative Cardiac Workup on PPI Therapy

Initial Risk Stratification Before Discharge

The American Gastroenterological Association recommends screening for alarm features, such as age-dependent threshold, unintentional weight loss, dysphagia, odynophagia, persistent vomiting, evidence of GI bleeding, palpable abdominal mass, or jaundice, before prescribing a PPI and discharging, particularly in Western populations over 60 years old 1
Patients on regular NSAIDs require endoscopy rather than empirical therapy due to a higher risk for peptic ulcer disease and complications 1
Symptoms present for less than 4 weeks may be managed with reassurance and over-the-counter medications with watchful waiting, while symptoms ≥4 weeks warrant either H. pylori testing or empirical PPI therapy 1

The American College of Gastroenterology recommends initiating full-dose PPI therapy as first-line treatment for patients with epigastric pain/burning without alarm features, as PPIs effectively control acid-related symptoms in functional dyspepsia when epigastric pain is the predominant symptom 1
Response to therapy confirms the acid-related nature of symptoms and validates the empirical approach 1

Patients should be counseled to return immediately for alarm symptoms, such as new dysphagia, vomiting, weight loss, or bleeding, or if symptoms persist beyond 8 weeks of therapy 1

The American Gastroenterological Association suggests that testing for H. pylori and treating if positive is a cost-effective and safe alternative to empirical PPI therapy in low-risk patients with symptoms ≥4 weeks, although many infected patients will not experience symptom resolution after H. pylori eradication 1
The primary benefit of H. pylori test-and-treat strategy is eliminating future peptic ulcer mortality risk rather than immediate symptom control 1

If symptoms persist after 8 weeks of PPI therapy, consider referring for endoscopy to evaluate for structural disease, as persistent symptoms may indicate misclassification or non-acid-mediated pathology 1

The American College of Gastroenterology advises against discharging patients on chronic NSAIDs without endoscopy, as they require evaluation for peptic ulcer disease and may need gastroprotection strategies beyond simple PPI therapy 1
Do not assume all upper GI symptoms are benign in patients over 60 years or those with alarm features—these patients require endoscopy before empirical therapy 1
The European Society for Clinical Gastroenterology recommends against continuing PPI indefinitely without reassessment, as many patients do not require long-term therapy, and attempt withdrawal after the initial treatment course if symptoms resolve 2